Method | Amplification strategy | Linearity, (ng mL−1) | LOD, (ng mL−1) | Refs. |
---|---|---|---|---|
Chemiluminescence and enzyme-linked immunosorbent | ECL-ELISA based on anti-FB1 IgG and HRP | 0.14–0.9 | 0.09 | [17] |
Chemiluminescence | Charge-coupled device | 2.5–500 | 2.5 | [18] |
Fluorescence | Anti apt/Apt-NH2/TiO2-PSi | 0.001–10 | 0.21 × 10−3 | [5] |
Fluorescence resonance energy transfer | AuNPs-MB-UCNPs | 0.01–100 | 0.01 | [19] |
Electrochemiluminescence | MIP/Ru@SiO2/CS/AuNPs/GCE | 1 × 10−3 ~ 100 | 0.35 × 10−3 | [6] |
Electrochemical immunosensor | AP-anti-antibody/anti-FB1/FB1-BSA-SWNTs/CS/GCE | 0.01–1000 | 2 × 10−3 | [20] |
Electrochemical immunosensor | Ab-AuNPs-PPy/ErGO-SPE | 200–4500 | 4.2 | [21] |
Electrochemical magneto immunosensor | FB1-HRP/Ab-FB1/MB&protein G/CSPE | 0.73–11.2 | 0.33 | [22] |
Electrochemical aptasensor | Apt-AuNPs-SPCE | 1 × 10−2~50 | 3.4 × 10−3 | [7] |
Electrochemical aptasensor | GS-TH/S2/S1/Au/GCE | 1 × 10−3~1000 | 1 × 10−3 | [23] |
Electrochemical aptasensor | Exo-I/Apt/cDNA/AuE | 1 × 10−3~1000 | 0.15 × 10−3 | This work |